Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
Rhea-AI Summary
Elutia Inc. (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix products, has announced it will release its second quarter 2024 financial results after market close on Wednesday, August 7, 2024. The company's management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
Investors can access the conference call through a webcast or by phone using the following details:
- U.S. Investors: 877-407-8029
- International Investors: 201-689-8029
- Conference ID: 13747696
A live and archived webcast of the event will be available on the 'Investors' section of the Elutia website at https://investors.elutia.com/.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ELUT gained 0.55%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SILVER SPRING, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that it will release its second quarter 2024 financial results after market close on Wednesday, August 7, 2024. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13747696
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at https://investors.elutia.com/.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
FAQ
When will Elutia (ELUT) release its Q2 2024 financial results?
What time is Elutia's (ELUT) Q2 2024 earnings call scheduled for?
How can investors access Elutia's (ELUT) Q2 2024 earnings call?
Where can I find the webcast for Elutia's (ELUT) Q2 2024 earnings call?
